ArticleJournal of colloid and interface science2025
Multifunctional slippery nanoemulsion-infused porous nitric oxide-releasing surfaces.
Article in Journal of colloid and interface science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Slippery bioactive nanoemulsion-infused and nitric oxide-releasing surfaces for anti-fouling biomedical applications.Biomaterials science · 2026Article
- Dual-action prevention of adherent and non-adherent biofoulingBiomaterials science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The need for biocompatible materials for medical devices remains critical, as complications such as infection, thrombosis, and biofouling significantly contribute to medical device failure and patient morbidity and mortality. In recent years, nitric oxide (NO)-releasing technologies have been explored to mitigate bacterial infections, particularly those stemming from common gram-positive and gram-negative bacterial pathogens. However, NO-releasing materials do not inherently possess anti-fouling capabilities. Combination strategies that use NO and anti-fouling surfaces (e.g., slippery lubricant-infused porous surfaces) have been explored to compensate for the deficit. In this work, a novel material was developed and assessed that combines the antibacterial capabilities of a NO-releasing substrate with the anti-fouling effects of a nanoemulsion (NE)-infused slippery surface. Using a covalently bound NO donor (S-nitroso-N-acetylpenicillamine, SNAP) to poly(dimethylsiloxane) (PDMS) and infused with a NE, denoted as SNAP-PDMS-NE, the NO release was sustained for 7 days. In addition to the prolonged NO release, the infused NE layer maintained a slippery nature and sliding angle below 20° for 7 days. The reported NO-releasing NE-swelled surface efficiently reduced Staphylococcus aureus adhesion by 3.5 log and Escherichia coli adhesion by 1.5 log after 24 h, reduced platelet adhesion by 89.92 %, and remained cytocompatible with relative cell viability greater than 70 %.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.